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Abstract
This paper describes the use of a unique ”Learning and Feedback” approach to tailor cancer 
clinical trials education programs for Community Bridges, a peer training intervention designed 
for African American communities in North Carolina. Generic community education modules 
were demonstrated with key community leaders who were designated as trainers. Quantitative and 
qualitative assessments were provided on understanding of content, comfort with material and 
cultural relevance. The generic materials were adapted into three revised modules, all featuring 
key messages about cancer clinical trials, discussion regarding distrust of medical research, 
common misconceptions about trials, patient protections, and a call to action to prompt increased 
inquiry about locally available trials. The revised modules were then used as part of a train-the-
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trainer program with 12 African American community leaders. ENACCT’s use of the Learning 
and Feedback process is an innovative method for culturally adapting clinical trials education.
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Introduction
Overall, the rate of adult participation in cancer clinical trials is less than 3% nationally, and 
participation is even lower in communities of color [1, 2]. African-Americans experience an 
unequal burden of cancer mortality and yet remain underrepresented in adult cancer clinical 
trials (CCTs). A number of barriers that negatively affect CCT participation have been cited 
in the literature [3]. These include barriers related to lack of knowledge and as well as public 
attitudes and beliefs about research [4–6] Several studies have suggested minorities may be 
more likely than Whites to have mistrust or distrust in research [7–9]. Yet some have 
suggested that distrust does not necessarily impact interest in learning about research 
participation or willingness to participate [10–13]. Despite willingness, however, minorities 
are less likely to be asked [10].
Increasing access to clinical trials is important but not sufficient. Reversing this trend 
requires increasing minority groups’ awareness of clinical trials [8]. Numerous experts have 
suggested that improving general cancer clinical trial awareness, access, and acceptability as 
well as addressing distrust may potentially help overcome barriers to [3,8,14–17]. Key 
education messages in particular should be targeted to address unique interests and concerns 
African- Americans have regarding research participation. Further, community members 
should be directly engaged in collaborating on the development of message content in order 
to increase the impact of education activities and acceptance of clinical trials. Use of group 
targeted messaging has been identified in the literature as an important form of 
customization along the continuum of tailored health communications [18].
Community-based organizations, due to their strong local connections and regard as trusted 
sources of social and informational support, can play an important role in articulating 
community challenges regarding trial participation and identifying methods of intervention 
to address these concerns. Interventions designed to influence social norms through key 
opinion leaders can effectively prompt individuals’ behavior changes in the community [19].
Community Bridges to Cancer Clinical Trials, an intervention led by Project Connect and 
the Carolina Community Network, was designed with the goal of raising community 
awareness and supporting informed decision-making about participation in cancer research. 
The Community Bridges to Cancer Clinical Trials, an intervention led by Project Connect 
and the Carolina Community Network, was designed with the goal of raising community 
awareness and supporting informed decision-making about participation in cancer research. 
The Community Bridges team collaborated with the Education Network to Advance Cancer 
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Clinical Trials (ENACCT) to adapt ENACCT’s generic cancer clinical trials education 
modules as part of the Community Bridges project. In this paper, we describe the 
collaborative process among academic and community partners involved in customizing 
cancer clinical trials education for African- American communities in North Carolina.
Methods
In March 2009, 12 community trainers were recruited from among four community-based 
organizations serving African-American communities in North Carolina. Each organization 
selected for participation in the project had significant experience with community outreach 
in breast or prostate cancer education in the African-American community. Six 
organizations responded to a public call for community partners to develop and pilot cancer 
clinical trial materials. Applications elicited the organization’s perceptions of minority 
participation in cancer research, cancer-related outreach activities and experiences, and 
organizational capacity to serve as community partners over the period of the initiative. 
Following an independent review of applications, four non-profit organizations were 
selected based on the aforementioned characteristics:
• Black Men’s Health Initiative conducts prostate cancer outreach and education 
within barbershops and collaborated on the development of a summer health theater 
production on prostate cancer.
• Community Health Coalition, Inc. provides screenings and outreach to local 
churches using monthly health tip newsletters.
• Crossworks, Inc. conducts breast cancer lay health advisor training for community 
members and cosmetologists to encourage screening and breast exams.
• North Carolina Institute for Minority Economic Development provides prostate 
cancer ambassador training for lay health leaders and coordinates annual prostate 
cancer screening events and educational conferences.
A stepwise process of curriculum development was used to adapt and implement 
ENACCT’s train-the-trainer workshop. Between March and May 2009, ENACCT 
conducted three 4-h Learning and Feedback sessions with Community Bridges project staff 
and community organization representatives. At each session, ENACCT demonstrated one 
of its education modules, previously shown as effective in the community setting [16]. Each 
was 1.5h and contained similar components: an introduction, didactic slide presentation, one 
follow-up small group exercise, a role-play activity, and closing featuring a call to action of 
talking to others about cancer clinical trials in the community. Each module included trial 
risks and benefits, patient protections, reasons for low rates of participation, and ways of 
accessing information about locally available trails. Grounded in Rogers’ diffusion of 
innovations theory, the modules focused on providing community leaders with information 
about trials to encourage them and their peers to actively discuss cancer clinical trials with 
patients and others as a high quality treatment option [20]. The modules also drew upon 
Bandura’s social cognitive theory, promoting individually focused activities in knowledge 
acquisition and self-efficacy to change behavior (i.e., trainers training peers) [21, 22]. 
Immediately following each demonstration, the featured module was discussed by all 
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session participants using a quantitative ranking questionnaire to identify areas of consensus 
on the most needed changes to the module (see Table 1). Qualitative feedback was also 
solicited regarding the module’s cultural relevance to African-American communities 
assessing language, length, imagery, key messages, and the calls to action.
After each session, ENACCT staff used feedback to make revisions to text and visual 
content. Follow-up conference calls facilitated by Community Bridges and ENACCT staff 
occurred 2–3 weeks following each session to preview the revised module content among 
participating community representatives for final refinement (see Table 2).
Results
Through facilitated large group discussion, participants prioritized content features most in 
need of adaptation. The most significant aspect of cancer clinical trials messaging which 
community representatives identified included the following: 1) increased flexibility in 
delivery format and length of training, 2)acknowledgment of community members’ concerns 
and questions about trial participation, 3) use of specific and personal examples to illustrate 
the connection between advances in cancer care and cancer clinical trials, and 4) 
development of brief, easy-to-remember call to action message. Table 3 details specific 
adaptations made for each main category of changes.
Increased Flexibility in Delivery Format and Length of Training
Community leaders expressed concerns regarding the duration of the training, the use of 
jargon to explain how trials work, and the need to foster trust with communities participating 
in workshops. Using these priority areas, ENACCT adapted the demonstrated modules into 
three revised formats, including “What Are Cancer Clinical Trials and What Do They Mean 
for My Community?,” a revised 90-minute workshop including a presentation with 
slides"Why Our Community Needs to Know about Cancer Clinical Trials,” a flexible “call 
and response” format, approximately 1 h in length, addressing myths and facts about clinical 
trials, and “Mr. Wilson” and Mrs. Woods,” two versions of a 40-minute narrated role-play 
featuring the personal story of a cancer patient in the form of a “photonovel” discussing their 
treatment options, followed by guided discussion.
Acknowledgement of Community Members’ Concerns and Questions about Trial 
Participation
The Call and Response module, patterned after a tradition found among many Black 
churches where congregants speak back to persons in the pulpit to acknowledge agreement, 
was formatted to initiate group discussion, allowing participants to brainstorm questions and 
reservations regarding clinical trials prior to delivery of the presentation. Based on 
participant feedback, trainers had the flexibility to focus on the sections of presentation that 
were most relevant to the group. Additionally, within the role-play formats, family members 
and patients were featured as characters expressing uncertainty and exploring myths 
surrounding trial participation. Providers featured in the role-play offered information about 
cancer clinical trials to the characters to address concerns while reinforcing the patient’s 
autonomy in treatment decision-making. The trainers’ guide for all formats prompted 
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trainers to disclose their role as community volunteers and indicate that training did not 
promote any particular trial or drug company.
Further changes to address community concerns included insertion of salient imagery 
featuring African- Americans to support the slide presentation and expanded discussion 
regarding the impact of limited minority participation in trials. Specifically, group 
discussion was incorporated into the standard workshop and call and response formats to 
allow time for participants to explore how low rates of participation among communities of 
color impact trial outcomes and the effectiveness of new treatments resulting from cancer 
research. The exercise allowed audience members to articulate the consequences of limited 
minority involvement in their own words and realize the need for taking action. Complex 
wording throughout the modules was substituted with simpler terms to describe concepts 
like randomization, standard of care, and informed consent. Clinical trials were highlighted 
consistently as a quality treatment option for cancer care. Costs and coverage concerns were 
addressed by including resources to address needs of patients who may be uninsured or 
underinsured.
Specific Examples Illustrate the Connection between Advances in Cancer Care and Cancer 
Clinical Trials
Community members indicated that exercises in the modules highlighting the benefits of 
clinical trials to society were helpful and should be expanded. In response, each revised 
format was designed to convey how clinical trials contribute to progress in patient care, with 
the standard workshop format specifically detailing ways in which treatment modalities for 
cancer and other health conditions have been improved as a result of medical research. This 
included a revised icebreaker exercise to share examples of medicines that resulted from 
past clinical trials. To further personalize examples, role-play was adopted as one of the 
revised module formats to convey the experiences of a male and female cancer patient as 
they considered cancer clinical trials as a treatment option. For other formats, inclusion of 
personal testimony from past clinical trial participants was encouraged.
Development of Brief and Easy-to-Remember Call to Action Messages
During the Learning and Feedback sessions, community leaders expressed uncertainty 
regarding the main call to action that the curriculum sought to communicate. Each module 
was revised to include core key messages about the local cancer burden and cancer clinical 
trials, African Americans’ distrust of medical research, common misconceptions about trials, 
and patient protections. A set of revised call to action messages was then developed by the 
entire group in order to prompt increased inquiry about locally available trails as well as join 
a local research registry. All modules also included language prompting trainers to clearly 
state the call to action messages of the workshop at the beginning of the session. Messages 
were formatted into a succinct, easy-to-recall acronym"Why CARE about Cancer Clinical 
Trials?” and were prominently featured in curriculum materials (see Figure 1). The four key 
messages linked to the acronym included the following:
• Cancer clinical trials are on option in quality treatment.
• African –Americans should ask their doctor about cancer clinical trials.
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• Rights are protected of everyone who participates in research.
• Everyone in North Carolina is affected by cancer.
Community Leader Training on Revised Modules
In August 2009, community leaders who participated in the Learning and Feedback sessions 
attended a 16-h train-the-trainer program facilitated by ENACCT to launch use of the 
revised modules. Trainers reviewed essential concepts regarding clinical trials including 
randomization, trial phases, and their purpose, as well as use of placebo. Participants became 
familiar with techniques for teaching adult learners, how to use the training evaluation 
instruments, and trainers practiced delivery of module content. At the end of each practice 
delivery, presenters received immediate feedback on the presentation style and the accuracy 
of their answers in response to question from the audience
Qualitative feedback on the Learning and Feedback process among community trainers, 
such as the comment from a trainer below, suggests the experience was instrumental in 
positively influencing attitudes regarding cancer research and their willingness to talk with 
peers about clinical trials.
[Community Bridges] approached programs that had extensive outreach in hard to 
reach communities and had an established track record of success and they chose 
those entities to introduce the clinical trials training and they listened. So although 
they came in with models of approaches, we spent a lot of time and a lot of hours, 
incorporating the input of those organizations that were selected to participate. 
There are a lot of people and a lot of institutions that don’t do that and the end 
product was something that we thought would have a chance to work because we 
had buy-in through the process. We were engaged throughout the process and in 
the end, we were allowed to introduce it to the community in our own way that’s 
already been established by our years of work and our outreach.
Discussion
Few examples exist in the literature regarding best practices to overcome barriers to 
awareness, opportunity, and acceptance of clinical trial participation [3]. While other 
interventions have included a focus on community-based cancer clinical trials education, the 
evidence in the literature is limited regarding effective approaches to cultural adaptation of 
cancer clinical trials education [17, 23–25]. ENACCT’s use of Learning and Feedback 
sessions in the Community Bridges project is an innovative, collaborative method for 
culturally adapting cancer clinical trials education messaging, resulting in the development 
of multiple, flexible, interactive training formats and greater community ownership of 
training content. Specifically, ENACCT’s use of this technique is unique in the extensive 
cocreation of key education messages with community leaders, its rigorous training in 
fundamental clinical trial concepts for trainers, and its expectation of significant practice 
among trainers prior to delivery in the community. This method of stakeholder engagement 
is a promising approach for adapting educational messaging for other diverse populations. 
Empowering community members with the knowledge and skills to advocate for greater 
access to cancer care choices is a significant step forward in changing awareness and social 
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acceptability of cancer research participation. It also improves individuals’ ability to make 
more informed decisions about selecting a cancer clinical trial as a high quality treatment 
option. Further study is warranted to assess the relative effectiveness of this approach across 
different populations and identify the most salient call to action messages that work best for 
each group, recognizing that these messages may vary accordingly.
One important limitation of this approach to note is the time-intensive nature of the process, 
which requires commitment from community members to provide substantive input on 
recommended improvements and then complete several rounds of follow-up review. 
Institutions or organizations seeking to replicate this approach should therefore take this into 
account when considering a timeline for curriculum development and implementation.
Finally, efforts to enhance community awareness and engagement in clinical trials cannot 
effectively be done independently. Without corresponding changes occurring within the 
cancer care systems serving the community, the likelihood of success will be minimal. In 
community settings as well, interventions are needed to improve the quality of 
communication between patients and providers to ensure a two-way dialogue regarding the 
availability, acceptability, and appropriateness of cancer clinical trials as a quality treatment 
option.
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1. The purpose of the project is clear and would help people in my community 
understand the context for this training
2. The icebreaker would be meaningful for the community members to whom I 
would be presenting
3. The video clip discussion would be meaningful for the community members to 
whom I would be presenting
Yes/No/Comments     a. I would be comfortable presenting these video clips and running a discussion 
on them Y/N
4. The content presented is relevant to the community members to whom I would 
be presenting
5. The content allows participants to relate the content to their own experiences
6. The content adequately addresses the concerns of my community when it comes 
to cancer clinical trials.
7. The key messages of the training are clear
8. The key messages of the training are easy to remember
9. The “call to action” of the training is clear
10. The “call to action” of the training would be easy for people in my community 
to do
11. The language used would be easy for the community members to understand
12. The language used is meaningful to the community members to whom I would 
be presenting
13. The images used are relevant to the community members to whom I would be 
presenting
14. The group activity (small group) helps reinforce the content of the training and 
it is realistic for people in my community to take part in.
Yes/No/Comments     a. I would be comfortable presenting this small group activity Y/N
15. The group activity (role play) would be helpful for people in my community to 
practice and it’s realistic that people would participate
Yes/No/Comments     a. I would be comfortable running this role-play Y/N
16. The delivery of the material allows for active discussion between trainer and 
participants
17. The delivery of the material keeps participants engaged by using different 
techniques to illustrate key points (combining activities of listening, watching, 
reading, and speaking)
18. The pace of each segment (Intro, icebreaker, video clips, slide presentation, 
group activity, role play, closing) is appropriate.
19. As a whole, how would people in your community respond to this workshop?
20. Other suggestions for improvement
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Table 2
Timeline
Date Community Bridges Activity
March 2, 2009 Kickoff Meeting with Community Leaders
March 26, 2009 Learning and Feedback Session # 1
April 8, 2009 Review and Editing Meeting with Community Leaders
April 21, 2009 Learning and Feedback Session # 2
May 11, 2009 Learning and Feedback Session # 3
May 21, 2009 Review and Editing Meeting with Community Leaders
June 2, 2009 Review and Editing Meeting with Community Leaders
June 17, 2009 Review and Editing Meeting with Community Leaders
July 15, 2009 Review and Editing Meeting with Community Leaders
August 12, 2009 Review and Editing Meeting with Community Leaders
August 26–27, 2009 Training of Training Program Featuring Revised Modules




















Module 1 Module 2 Module 3
Increased flexibility 
in delivery format 
and length of 
training content
• Revised to 90 minute 
Workshop format “What 
Are Cancer Clinical Trials 
and What Do They Mean 
for My Community?”
• Revised to two role-
play Photo-novels 
“Ms. Woods” (breast 




• Revised to “Call and 
Response” session “Why 
Our Community Needs 
to Know About Cancer 
Clinical Trials”, a 
participant-guided 





concerns about trial 
participation
• Included trainer disclaimer indicating trainers are not promoting any particular trial for enrollment
• Highlighted clinical trials as a quality treatment option for care
• Addressed guinea pig fears, standard vs. experimental care and myths regarding participation (e.g. 
clinical trials as a “last resort”)
• Explored role of low rates of participation among communities of color on trial outcomes and the 
effectiveness of new treatments resulting from cancer research
• Substituted simpler terms to describe randomization, standard of care, informed consent, etc.
• Added images of African Americans to represent “the faces of cancer clinical trials”
• Included optional video clips featuring African American doctors and trial participants to supplement 
slide presentation
• Added resources for identifying locally available trials
• Highlighted clinical trials as a quality treatment option for care
• Included resources included to address needs of patients who may be uninsured or underinsured
Specific and 
personal examples to 
make the connection 
of advances in 
cancer care to 
cancer clinical trials
• Revised icebreaker to share examples of medicines that resulted from past clinical trials
• Encouraged discussion of personal experiences with cancer diagnosis and treatment decision-making 
(through testimony of past trial participants or as illustrated in role play)
Development of 
brief, easy to 
remember call to 
action messages
• Added language for trainers to clearly state the intention and call to action messages of the workshop at 
the beginning of the session
• Created “Why CARE” tagline featuring 4 key cancer clinical trials awareness and action messages
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